Hospira Recalls Epinephrine Injection Due to Sterility Concerns
Hospira, Inc. recalled 49,620 vials of Epinephrine Injection on August 4, 2025. The recall follows concerns about the lack of assurance of sterility. Consumers should stop using the product immediately.
Product Details
The recalled product is Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL). It was distributed by Hospira, Inc. and is identified by NDC 0409-4933-05.
The Hazard
The recall stems from a lack of assurance of sterility. This poses a high risk of infection and serious health complications for users.
What to Do
Stop using the product immediately. Contact Pfizer Inc. or your healthcare provider for guidance on returning the product.
Contact Information
For more information, visit the FDA recall page or contact Pfizer Inc. directly for assistance and guidance.